ID: ALA2377261

Max Phase: Preclinical

Molecular Formula: C22H29NO3

Molecular Weight: 355.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)N(CCOC(=O)C(O)(c1ccccc1)c1ccccc1)C(C)C

Standard InChI:  InChI=1S/C22H29NO3/c1-17(2)23(18(3)4)15-16-26-21(24)22(25,19-11-7-5-8-12-19)20-13-9-6-10-14-20/h5-14,17-18,25H,15-16H2,1-4H3

Standard InChI Key:  NHFIEMNGVIAFJO-UHFFFAOYSA-N

Associated Targets(Human)

Muscarinic acetylcholine receptor M1 and M3 256 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 7750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M2 10671 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M1 12690 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 355.48Molecular Weight (Monoisotopic): 355.2147AlogP: 3.58#Rotatable Bonds: 8
Polar Surface Area: 49.77Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.06CX Basic pKa: 9.52CX LogP: 4.11CX LogD: 2.16
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.74Np Likeness Score: -0.55

References

1. Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK..  (2013)  Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,  21  (9): [PMID:23523385] [10.1016/j.bmc.2013.01.072]

Source